Hyperactivation of SREBP-1c induces hepatic lipid accumulation [5, 6, 7], indicating that SREBP-1c-associated de novo lipogenesis is an important target of hepatic steatosis. This evidence concerns the gene SREBF1 and fatty liver disease.